About Michael Rubin
Form D filings for Scipher Medicine from 2019 to 2021 list Michael Rubin as director.
Michael Rubin first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Rubin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Rubin works with at each company, as listed on that company's latest Form D.
Scipher Medicine Corp · Form D/A, Mar 31, 2021
TS
Todd Sone
Director
Alif Saleh
Executive officer and director
JS
Jeffrey Sachs
Secretary
AB
Albert Laszlo Barabasi
Director
JL
Joseph Loscalzo
Director
SK
Samir Kaul
Director
MK
Miklos Kobor
Director